Cite
HARVARD Citation
Tabrizi, S. et al. (n.d.). J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington's disease, results of the first htt-lowering drug trial. Journal of neurology, neurosurgery and psychiatry. pp. A97-A98. [Online].